tazarotene has been researched along with fluocinonide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ast, E; Callen, JP; Chandraratna, RA; Cullen, SI; Gibson, JR; Hong, SR; Kulp-Shorten, CL; Lebwohl, M; Lowe, NJ; Lue, JC; Phillips, TJ; Quell, JM; Rosen, T; Sefton, J; Wolf, DI | 1 |
| Marks, R | 1 |
| Hecker, D; Lebwohl, M; Worsley, J; Yueh, G | 1 |
1 review(s) available for tazarotene and fluocinonide
| Article | Year |
|---|---|
The role of tazarotene in the treatment of psoriasis.
Topics: Administration, Topical; Dermatologic Agents; Fluocinonide; Humans; Nicotinic Acids; Psoriasis | 1999 |
1 trial(s) available for tazarotene and fluocinonide
| Article | Year |
|---|---|
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents; Child; Dermatologic Agents; Erythema; Female; Fluocinonide; Follow-Up Studies; Gels; Glucocorticoids; Humans; Life Tables; Male; Middle Aged; Nicotinic Acids; Prodrugs; Psoriasis; Safety; Single-Blind Method; Skin; Treatment Outcome | 1998 |
1 other study(ies) available for tazarotene and fluocinonide
| Article | Year |
|---|---|
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis | 2000 |